Misuse of Drugs Act

Debate between Baroness Laing of Elderslie and Jeff Smith

Thursday 17th June 2021 Commons Chamber

[Jeff Smith]

I thank the Minister for his response—I am pleased that he is open to listening on this issue—and my good friend, my hon. Friend the Member for St Helens North (Conor McGinn), and the SNP spokesperson, the hon. Member for Cumbernauld, Kilsyth and Kirkintilloch East (Stuart C. McDonald), for their contributions, although I agree with the SNP spokesperson that it is regrettable that those three individuals, rather than health representatives, should be responding to a debate on drug policy.

We await the second report of the Carol Black review. The first report set out the very significant problems very well. However, the Government were very clear, in the remit she was given, that she is not able to look at legislative change, and I think that it is regrettable. I agree actually with the Minister that there is no silver bullet. This is a complex issue, and all I have been saying really, and all that most people have been saying, is: let us look at the evidence, let us review the Act and let us see if it is still fit for purpose. I personally do not think that is too much to ask.

This is the first time we have had a debate on drug policy in this Chamber since 2017, which is a shame because it is an issue in many—probably most—of our constituencies. As politicians, we really need to address this issue thoughtfully and with careful consideration to find the right way forward. I hope it is not another four years before we discuss this issue and look at the best way forward by looking at the evidence of how we reduce harm to our communities.

Finally, I thank all the speakers who have taken part in the debate today and, again, the Backbench Business Committee for allowing the time.

Question put and agreed to.

Resolved,

That this House has considered the Misuse of Drugs Act 1971.

[Madam Deputy Speaker (Dame Eleanor Laing)]

I will now suspend the House for three minutes in order to allow arrangements to be made for the next item of business.

Medical Cannabis under Prescription

Debate between Baroness Laing of Elderslie and Jeff Smith

Monday 20th May 2019 Commons Chamber

[Jeff Smith]

That is not an unusual case. There are lots of people who want to use medical cannabis and do not want to buy it from the street or go to Holland to import cannabis products, and they are frustrated.

I will wind up, because I have been speaking for longer than I intended. On the funding issue, there are cases of clinicians being willing to prescribe but being blocked by trusts or CCGs. What is the Minister’s understanding of how many cases there are where funding is the issue, rather than prescription? Even where clinicians are willing to prescribe and there is new thinking, CCGs do not have budget lines for some of these products, so the reluctance is understandable. I am interested to know whether the Minister has any information on that.

It might cost more for the NHS to supply more medical cannabis prescriptions, but we have to compare that with the reduction in other costs. The estimate is that opioid costs would be 25% lower, and there would be fewer hospital admissions. Professor Mike Barnes said in his evidence to the Select Committee that we could probably introduce medical cannabis in this country on the NHS at no net cost, when we take into account the reduced costs elsewhere.

Our system is clearly too restrictive. It is not working. We need creative thinking and flexibility from the Government, and we need them to look at the different types of evidence from around the world. There are people in this country who, if they were living in Holland, Australia or Canada, would be able to get on with their lives, get their cannabis products legally and not have the worries of the campaigners in our Gallery today about them or their children and relatives having to go through chronic pain or the episodes of epilepsy that we have seen in young patients over the last year.

We all want to make some progress and are desperately frustrated that we are not able to get anywhere. I refer the Minister to the evidence given by Professor Mike Barnes. We need to look at other types of evidence to inform ourselves of a way to deliver the products that our patients need into their hands.

[Madam Deputy Speaker (Dame Eleanor Laing)]

The hon. Gentleman made reference to the late Member for Newport West. The House will remember fondly that the late Paul Flynn raised this subject in the House persistently over many decades, and got very little support. I keep looking behind me, expecting to see him there in his usual place—

Business of the House

Debate between Baroness Laing of Elderslie and Jeff Smith

Thursday 26th January 2017 Commons Chamber

[Jeff Smith (Manchester, Withington) (Lab)]

rose—

[Madam Deputy Speaker (Mrs Eleanor Laing)]

And the prize for patience goes to Jeff Smith.

[Jeff Smith]

Thank you, Madam Deputy Speaker.

[Madam Deputy Speaker]

And I wish the hon. Gentleman a happy birthday.

[Jeff Smith]

Thank you also for that, Madam Deputy Speaker—I am grateful.

It is quite right, of course, that other parliamentary business should be shelved over the next couple of weeks so that we can debate article 50, and that includes the Bus Services Bill. In Manchester, we have been demanding London-style bus franchising powers for many years. We can wait a little longer, but may I encourage the Leader of the House to reschedule the Bus Services Bill as soon as possible after the recess so that Manchester can properly manage its transport network?